COVID-19 Planning and Guidance for Clinical Research

COVID-19 Planning and Guidance for Clinical Research

ACCORD Guidance for Restarting/Commencing Non-COVID-19 Clinical Research

ACCORD Restart Risk Assessment Checklist

ACCORD COVID-19 Clinical Research Plan and Guidance
Click here for specific guidance around how to manage clinical research

ACCORD Study Specific Risk Assessment for Potential Impact of COVID-19

Click here for FAQs

Public Involvement for COVID-19 Studies

In late March the Health Research Authority became aware of concerns that COVID-19 research was taking place without adequate public involvement. They analysed the first 40 applications received through the COVID-19 fast-track study review service; only 20% of applicants said they had or intended to involve the public in their study. This compares to 78% in a similar period last year.

The Patient and Public Advisory Service in Edinburgh can provide invaluable advice and support with public involvement. For further information, contact Carol Porteous.

Useful links:

MHRA Guidance on coronavirus (COVID-19) 

HRA: Guidance for sponsors, sites and researchers

HRA: Guidance on health and social care research projects for educational research (HRA now stopped reviewing applications for individual undergraduate and masters student projects from now until further notice)

UKRI Guidance